Glucose Lowering: New Options.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 35, doi. 10.1177/155989771010023
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2010 AND VI 10 AND IP 10
Results: 23
1
2
CIMT: Screening Asymptomatic High-Risk Patients.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 34, doi. 10.1177/155989771010022
- By:
- Publication type:
- Article
3
Antithrombotic Therapy in Atherosclerosis.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 33, doi. 10.1177/155989771010021
- By:
- Publication type:
- Article
4
Renal Function and Cardiovascular Diseases.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 30, doi. 10.1177/155989771010020
- By:
- Publication type:
- Article
5
The Role of Newer Anticoagulants in the Treatment of Atrial Fibrillation.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 28, doi. 10.1177/155989771010019
- By:
- Publication type:
- Article
6
Revascularization in High-Risk CAD.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 26, doi. 10.1177/155989771010018
- By:
- Publication type:
- Article
7
Cardiovascular Imaging: Evolving Challenges and Future Opportunities.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
8
Results from the ASCOT Trial.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 23, doi. 10.1177/155989771010016
- By:
- Publication type:
- Article
9
CLOSURE I: No Reduction in Recurrent Stroke or TIA with Septal Closure.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 22, doi. 10.1177/155989771010015
- By:
- Publication type:
- Article
10
No Reduction in Recurrent AF with Omega-3 Fatty Acids.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 21, doi. 10.1177/155989771010014
- By:
- Publication type:
- Article
11
Results from the ASCEND-HF Trial.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 20, doi. 10.1177/155989771010013
- By:
- Publication type:
- Article
12
High-Dose Clopidogrel in Patients with High Residual Reactivity: Results from the GRAVITAS Trial.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 19, doi. 10.1177/155989771010012
- By:
- Publication type:
- Article
13
Results from Symplicity HTN-2.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 18, doi. 10.1177/155989771010011
- By:
- Publication type:
- Article
14
Results from EMPHASIS-HF.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 17, doi. 10.1177/155989771010010
- By:
- Publication type:
- Article
15
SMART-AV: No Benefit to Customized AV Delay in CRT.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 17, doi. 10.1177/155989771010009
- By:
- Publication type:
- Article
16
ACT Trial Results Should Change Clinical Practice.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 16, doi. 10.1177/155989771010008
- By:
- Publication type:
- Article
17
BASKET-PROVE: DES Just as Safe as BMS in Large Coronary Vessels.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 15, doi. 10.1177/155989771010007
- By:
- Publication type:
- Article
18
Benefits of Inducing ApoA1 Synthesis Still Unclear: Results from ASSERT.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 14, doi. 10.1177/155989771010006
- By:
- Publication type:
- Article
19
DEFINE: CETP Inhibition with Anacetrapib Significantly Raises HDL Cholesterol and Further Lowers LDL.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 13, doi. 10.1177/155989771010005
- By:
- Publication type:
- Article
20
ROCKET-AF: Rivaroxaban Prevents Stroke as Effectively as Warfarin, with Lower Bleeding Risk.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 12, doi. 10.1177/155989771010004
- By:
- Publication type:
- Article
21
Systems of Care: The Latest Breakthroughs in Treating Cardiovascular Disease.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 10, doi. 10.1177/155989771010003
- By:
- Publication type:
- Article
22
Clopidogrel, Warfarin, and Statins: Pharmacogenetics versus Laboratory Monitoring - What You Need to Know.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 8, doi. 10.1177/155989771010002
- By:
- Publication type:
- Article
23
Preventing Cardiovascular Disease: Urgent Solutions for a Global Epidemic.
- Published in:
- MD Conference Express, 2010, v. 10, n. 10, p. 6, doi. 10.1177/155989771010001
- By:
- Publication type:
- Article